Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
NCT07893769Phase 1Completed
Phase 1, randomised, double-blind trial of ayahuasca (4 arms), sponsored by Universidade de São Paulo. Primary endpoint: NEO Five-Factor Inventory-Revised at 21 days. Started Jan 2024; status: completed.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on NCT07893769.